Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 9

Results For "2022"

1415 News Found

2022: Predictions for medical and healthcare industry
Opinion | December 20, 2021

2022: Predictions for medical and healthcare industry

2022 is going to be the year of opportunities and innovations from the medical industry in India


Most national diagnostic players to deliver double-digit revenue growth in FY2022: ICRA
News | December 15, 2021

Most national diagnostic players to deliver double-digit revenue growth in FY2022: ICRA

During H1 FY2022, the revenues and operating profit margin (OPM) for ICRA sample set showed sharp improvement aided by volume uptick in Covid-19 and allied tests and also demand traction for non-Covid tests


KOREA PACK and ICPI to be held in June 2022 in hybrid format
Packaging | December 13, 2021

KOREA PACK and ICPI to be held in June 2022 in hybrid format

KOREA PACK and concurrent event ICPI Week (Int’l Cosmetic and Pharmaceutical Industry Week) will be held as hybrid events in 2022


Lubrizol's polymer excipient Apisolex featured in Phase I candidate
News | June 11, 2025

Lubrizol's polymer excipient Apisolex featured in Phase I candidate

The use of Apisolex polymer excipient has been proven to increase the solubility of certain APIs by as much as 50,000-fold


Arvinas and Pfizer's Vepdegestrant significantly improves progression-free survival for patients with ESR1-Mutant, ER+/HER2- advanced breast cancer
Diagnostic Center | June 02, 2025

Arvinas and Pfizer's Vepdegestrant significantly improves progression-free survival for patients with ESR1-Mutant, ER+/HER2- advanced breast cancer

Vepdegestrant is the first and only PROteolysis TArgeting Chimera (PROTAC) evaluated in a Phase 3 clinical trial and the first to show benefit in patients with breast cancer


Biocon gets six-month extension on insulin supply pact in Malaysia
News | May 23, 2025

Biocon gets six-month extension on insulin supply pact in Malaysia

The company was awarded the insulins supply contract for a three-year period in 2022 through April 2025


Nureca receives approval for new manufacturing facility
News | April 23, 2025

Nureca receives approval for new manufacturing facility

This unit will focus on the manufacturing of health and wellness equipment


Paras Healthcare introduces radiation oncology facility at Ranchi
Healthcare | April 23, 2025

Paras Healthcare introduces radiation oncology facility at Ranchi

The newly inaugurated facility bridges this gap by offering metro-grade treatment closer to home


Aarti Pharmalabs achieves SBTi approval of GHG emission reduction targets
Sustainability | April 17, 2025

Aarti Pharmalabs achieves SBTi approval of GHG emission reduction targets

Aarti Pharmalabs becomes 6th Indian Pharma/CDMO to earn SBTi approval for all 3 Scopes since 2022 demerger


Asahi Kasei establishes Asahi Kasei Life Science to drive its bioprocess businesses
News | April 08, 2025

Asahi Kasei establishes Asahi Kasei Life Science to drive its bioprocess businesses

Asahi Kasei Life Science covers a broad range of bioprocess products and services